KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Equity Average (2020 - 2025)

Clover Health Investments' Equity Average history spans 6 years, with the latest figure at $324.8 million for Q4 2025.

  • For Q4 2025, Equity Average fell 4.93% year-over-year to $324.8 million; the TTM value through Dec 2025 reached $324.8 million, down 4.93%, while the annual FY2025 figure was $324.9 million, 3.56% up from the prior year.
  • Equity Average reached $324.8 million in Q4 2025 per CLOV's latest filing, down from $342.6 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $515.2 million in Q1 2022 to a low of -$12.1 million in Q1 2021.
  • Average Equity Average over 5 years is $347.7 million, with a median of $340.1 million recorded in 2023.
  • Peak YoY movement for Equity Average: soared 4347.65% in 2022, then crashed 34.01% in 2023.
  • A 5-year view of Equity Average shows it stood at $476.2 million in 2021, then decreased by 21.35% to $374.5 million in 2022, then fell by 18.8% to $304.1 million in 2023, then increased by 12.34% to $341.7 million in 2024, then fell by 4.93% to $324.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Equity Average are $324.8 million (Q4 2025), $342.6 million (Q3 2025), and $340.1 million (Q2 2025).